Equity Analysis

Quarterly Results

    Divis Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    532488
    INE361B01024
    474.522963
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    DIVISLAB
    77.63
    105890.11
    EPS(TTM)
    Face Value()
    Div & Yield %:
    51.38
    2
    0.75
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2023Sep 2023Jun 2023
Gross Sales1808.001868.001730.00
Other Operating Income0.000.000.00
Other Income 94.0085.0080.00
Total Income1902.001953.001810.00
Total Expenditure 1317.001394.001239.00
PBIDT585.00559.00571.00
Interest 0.001.000.00
PBDT585.00558.00571.00
Depreciation95.0094.0093.00
Tax121.00108.00123.00
Fringe Benefit Tax0.000.000.00
Deferred Tax11.0014.0010.00
Reported Profit After Tax358.00342.00345.00
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item358.00342.00345.00
EPS (Unit Curr.)13.5012.8912.99
EPS (Adj) (Unit Curr.)13.5012.8912.99
Calculated EPS (Unit Curr.)13.5112.9113.02
Calculated EPS (Adj) (Unit Curr.)13.5112.9113.02
Calculated EPS (Ann.) (Unit Curr.)54.0451.6252.08
Calculated EPS (Adj) (Ann.) (Unit Curr.)54.0451.6252.08
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity53.0053.0053.00
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)32.3629.9333.01
PBDTM(%)32.3629.8733.01
PATM(%)19.8018.3119.94
Dividend Per Share(Rs)0.000.000.00
Diluted EPS13.5012.8912.99